290 related articles for article (PubMed ID: 11188978)
1. Pathophysiologic basis of surgery for Parkinson's disease.
Obeso JA; Rodriguez-Oroz MC; Rodriguez M; Macias R; Alvarez L; Guridi J; Vitek J; DeLong MR
Neurology; 2000; 55(12 Suppl 6):S7-12. PubMed ID: 11188978
[TBL] [Abstract][Full Text] [Related]
2. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
3. [Neuronal activities in the ventrolateral thalamus and basal ganglia in relation to Parkinson's disease].
Wang J; Zhuang P; Li YJ
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(15):1021-6. PubMed ID: 16784702
[TBL] [Abstract][Full Text] [Related]
4. [Patterns of neuronal activity in the basal ganglia nucleus in parkinsonian patients with levodopa-induced dyskinesia].
Li XY; Zhuang P; Li YJ
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(23):1607-12. PubMed ID: 19035099
[TBL] [Abstract][Full Text] [Related]
5. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease.
Obeso JA; Rodríguez-Oroz MC; Benitez-Temino B; Blesa FJ; Guridi J; Marin C; Rodriguez M
Mov Disord; 2008; 23 Suppl 3():S548-59. PubMed ID: 18781672
[TBL] [Abstract][Full Text] [Related]
6. Surgical treatment of Parkinson's disease.
Obeso JA; Rodríguez MC; Gorospe A; Guridi J; Alvarez L; Macias R
Baillieres Clin Neurol; 1997 Apr; 6(1):125-45. PubMed ID: 9426872
[TBL] [Abstract][Full Text] [Related]
7. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
[TBL] [Abstract][Full Text] [Related]
8. Basal ganglia neural responses during behaviorally effective deep brain stimulation of the subthalamic nucleus in rats performing a treadmill locomotion test.
Shi LH; Luo F; Woodward DJ; Chang JY
Synapse; 2006 Jun; 59(7):445-57. PubMed ID: 16521122
[TBL] [Abstract][Full Text] [Related]
9. Deep brain stimulation.
Breit S; Schulz JB; Benabid AL
Cell Tissue Res; 2004 Oct; 318(1):275-88. PubMed ID: 15322914
[TBL] [Abstract][Full Text] [Related]
10. Effects of deep brain stimulation and medication on bradykinesia and muscle activation in Parkinson's disease.
Vaillancourt DE; Prodoehl J; Verhagen Metman L; Bakay RA; Corcos DM
Brain; 2004 Mar; 127(Pt 3):491-504. PubMed ID: 14662520
[TBL] [Abstract][Full Text] [Related]
11. Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation.
Ray NJ; Jenkinson N; Wang S; Holland P; Brittain JS; Joint C; Stein JF; Aziz T
Exp Neurol; 2008 Sep; 213(1):108-13. PubMed ID: 18619592
[TBL] [Abstract][Full Text] [Related]
12. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
[TBL] [Abstract][Full Text] [Related]
13. The subthalamic nucleus: a possible target for stereotaxic surgery in Parkinson's disease.
Guridi J; Luquin MR; Herrero MT; Obeso JA
Mov Disord; 1993 Oct; 8(4):421-9. PubMed ID: 8232351
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease.
Galati S; Mazzone P; Fedele E; Pisani A; Peppe A; Pierantozzi M; Brusa L; Tropepi D; Moschella V; Raiteri M; Stanzione P; Bernardi G; Stefani A
Eur J Neurosci; 2006 Jun; 23(11):2923-8. PubMed ID: 16819981
[TBL] [Abstract][Full Text] [Related]
15. The effects of subthalamic nucleus deep brain stimulation on parkinsonian tremor.
Diamond A; Shahed J; Jankovic J
J Neurol Sci; 2007 Sep; 260(1-2):199-203. PubMed ID: 17561121
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging-based morphometry and landmark correlation of basal ganglia nuclei.
Zhu XL; Hamel W; Schrader B; Weinert D; Hedderich J; Herzog J; Volkmann J; Deuschl G; Müller D; Mehdorn HM
Acta Neurochir (Wien); 2002 Oct; 144(10):959-69; discussion 968-9. PubMed ID: 12382123
[TBL] [Abstract][Full Text] [Related]
17. Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease.
Chastan N; Westby GW; Yelnik J; Bardinet E; Do MC; Agid Y; Welter ML
Brain; 2009 Jan; 132(Pt 1):172-84. PubMed ID: 19001482
[TBL] [Abstract][Full Text] [Related]
18. [Functional models of movement disorders of basal ganglia origin and effects of functional neurosurgery].
Hashimoto T
Rinsho Shinkeigaku; 2007 Jan; 47(1):21-6. PubMed ID: 17491332
[TBL] [Abstract][Full Text] [Related]
19. Subthalamic oscillatory activities at beta or higher frequency do not change after high-frequency DBS in Parkinson's disease.
Foffani G; Ardolino G; Egidi M; Caputo E; Bossi B; Priori A
Brain Res Bull; 2006 Mar; 69(2):123-30. PubMed ID: 16533660
[TBL] [Abstract][Full Text] [Related]
20. 300-Hz subthalamic oscillations in Parkinson's disease.
Foffani G; Priori A; Egidi M; Rampini P; Tamma F; Caputo E; Moxon KA; Cerutti S; Barbieri S
Brain; 2003 Oct; 126(Pt 10):2153-63. PubMed ID: 12937087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
